Showing results (141-150 of 1,916) with videos related to
Sort By:
Pageof 192
Current Drug Metabolism|July 24, 2001
Bestatin as an experimental tool in mammalsO A Scornik, V BotbolCurrent Drug Metabolism|July 27, 2001
Effective prodrug liposome and conversion to active metaboliteY SadzukaCurrent Drug Metabolism|July 27, 2001
Mechanisms of inhibitory and regulatory effects of methylenedioxyphenyl compounds on cytochrome P450-dependent drug oxidationM MurrayCurrent Drug Metabolism|July 3, 2002
Are chemically reactive metabolites responsible for adverse reactions to drugs?D P Williams, N R Kitteringham, D J Naisbitt, et al.Current Drug Metabolism|May 11, 2002
Neopterin as a marker for immune system activationC Murr, B Widner, B Wirleitner, et al.Current Drug Metabolism|July 23, 2003
Utility of Mdr1-gene deficient mice in assessing the impact of P-glycoprotein on pharmacokinetics and pharmacodynamics in drug discovery and developmentCuiping Chen, Xingrong Liu, Bill J SmithCurrent Drug Metabolism|July 23, 2003
The metabolism of diclofenac--enzymology and toxicology perspectivesWei TangCurrent Drug Metabolism|October 9, 2002
Cytochrome P450-based gene therapy for cancer treatment: from concept to the clinicYoussef JounaidiCurrent Drug Metabolism|October 9, 2002
Biological activities, mechanisms of action and biomedical prospect of the antitumor ether phospholipid ET-18-OCH(3) (edelfosine), a proapoptotic agent in tumor cellsConsuelo Gajate, Faustino MollinedoCurrent Drug Metabolism|August 22, 2001
Mechanism-based inactivators as probes of cytochrome P450 structure and functionU M Kent, M I Juschyshyn, P F HollenbergPageof 192